- Home
- HCM vs DEI Comparison
HCM vs DEI Comparison
Compare HCM & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- DEI
- Stock Information
- Founded
- HCM 2000
- DEI 1971
- Country
- HCM Hong Kong
- DEI United States
- Employees
- HCM N/A
- DEI N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- DEI Real Estate Investment Trusts
- Sector
- HCM Health Care
- DEI Real Estate
- Exchange
- HCM Nasdaq
- DEI Nasdaq
- Market Cap
- HCM 2.6B
- DEI 2.6B
- IPO Year
- HCM N/A
- DEI 2006
- Fundamental
- Price
- HCM $16.01
- DEI $15.02
- Analyst Decision
- HCM Sell
- DEI Hold
- Analyst Count
- HCM 1
- DEI 8
- Target Price
- HCM $13.75
- DEI $17.86
- AVG Volume (30 Days)
- HCM 56.9K
- DEI 1.6M
- Earning Date
- HCM 08-07-2025
- DEI 11-04-2025
- Dividend Yield
- HCM N/A
- DEI 5.05%
- EPS Growth
- HCM N/A
- DEI N/A
- EPS
- HCM 0.53
- DEI 0.22
- Revenue
- HCM $602,197,000.00
- DEI $1,001,173,000.00
- Revenue This Year
- HCM N/A
- DEI $2.92
- Revenue Next Year
- HCM $15.49
- DEI $2.16
- P/E Ratio
- HCM $5.91
- DEI $69.39
- Revenue Growth
- HCM N/A
- DEI 3.24
- 52 Week Low
- HCM $11.51
- DEI $12.39
- 52 Week High
- HCM $21.50
- DEI $20.50
- Technical
- Relative Strength Index (RSI)
- HCM 48.16
- DEI 38.62
- Support Level
- HCM $17.19
- DEI $15.34
- Resistance Level
- HCM $16.35
- DEI $15.83
- Average True Range (ATR)
- HCM 0.29
- DEI 0.33
- MACD
- HCM -0.01
- DEI -0.13
- Stochastic Oscillator
- HCM 21.74
- DEI 0.35
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.